Selegiline hydrochloride and cognition
Data up to Jan 2025
Total Citations Per Year
Abstract
References (23)
Effect of Deprenyl on the Progression of Disability in Early Parkinson's Disease
1989 • 913 citations
Deprenyl is metabolized to methamphetamine and amphetamine in man.
1978 • 287 citations
AGEING, MONOAMINES, AND MONOAMINE-OXIDASE LEVELS
1972 • 263 citations
Increased activity of brain and platelet monoamine oxidase in dementia of Alzheimer type
1980 • 254 citations
BRADYPHRENIA IN PARKINSON'S DISEASE AND PSYCHOMOTOR RETARDATION IN DEPRESSIVE ILLNESS
1987 • 220 citations
The possible mechanisms of action of (-)deprenyl in Parkinson's disease
1978 • 207 citations
A Controlled Study of the Antidepressant Efficacy and Side Effects of ( — )-Deprenyl
1989 • 175 citations
Effects of a MAO-B Inhibitor in the Treatment of Alzheimer Disease
1991 • 145 citations
The effect of β-phenylethylamine on central and peripheral monoamine-containing neurons
1967 • 133 citations
Cognitive effects of l-deprenyl in Alzheimer's disease
1987 • 127 citations
Neuropsychological Effects of L-Deprenyl in Alzheimerʼs Type Dementia
1990 • 114 citations
L-Deprenil, A Selective Monoamine Oxidase Type B Inhibitor, in the Treatment of Depression: A Double Blind Evaluation
1983 • 94 citations
Is the failure of (-)deprenyl, a selective monoamine oxidase B inhibitor, to alleviate depression related to freedom from the cheese effect?
1981 • 90 citations
Deprenyl in Parkinson disease
1981 • 88 citations
L-deprenyl, a selective monoamine oxidase type-b inhibitor in endogenous depression
1980 • 86 citations
l-Deprenyl in Atypical Depressives
1984 • 85 citations
Tyramine pressor sensitivity changes during deprenyl treatment
1985 • 81 citations
Phenylethylamine: evidence for a direct, postsynaptic dopamine-receptor stimulating action
1977 • 75 citations
Platelet MAO activity in primary degenerative dementia
1984 • 52 citations
Monoamine Oxidase and Dementia: Treatment with an Inhibitor of MAO-B Activity
1990 • 29 citations
The effect of deprenyl (selegiline) on cognition and emotion in parkinsonian patients undergoing long-term levodopa treatment
1983 • 27 citations
New approaches in the use of selegiline for the treatment of Parkinson's disease
1989 • 16 citations
Genetic Markers in Epilepsy
1981 • 14 citations